跳至主要内容
临床试验/CTRI/2025/07/090475
CTRI/2025/07/090475尚未招募3 期

Randomized open controlled clinical trial to evaluate the efficacy of Yamanipanchak vati in Balatisara W.S.R. Diarrhea in children.

Dr. Snehal Laxman Gaikwad1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年7月18日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
To study the efficacy of Yamanipanchak vati in Balatisara with special reference to Diarrhea in children.

研究概览

简要总结

Randomized open controlled clinical trial to evaluate the efficacy of Yamanipanchak vati in Balatisara W.S.R. to Diarrhea in children.

The assessment of signs and symptoms will be done at regular follow up.

Observation will be done from outcomes achieved in 7 days.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Age group 6 to 12 years irrespective of gender, irrespective of caste, socio-economic status, patients having Lakshnas of Balatisara like Malpravrutti, Udarashool, Aruchi, Daurbalya and Trushna.

排除标准

  • Patients having age group below 6 years and above 12 years.
  • Known case of patient with chronic disorder.
  • Patient on any other long term medications.
  • Known case of patients suffering from any systemic disease which intervenes with treatment.
  • Patients having chronic and recurrent phases of Balatisara will be excluded.
  • Patient having Atisarah due to food poisoning.
  • Patient of infective diarrhea.
  • Symptoms of some and severe dehydration are excluded.

结局指标

主要结局

To study the efficacy of Yamanipanchak vati in Balatisara with special reference to Diarrhea in children.

时间窗: 7 days

次要结局

  • 1. To study the efficacy of Yamanipanchak vati in Balatisara by Ayurvedic and Modern point of view.(2. To assess improvement in signs and symptoms of Balatisara after treating by Yamanipanchak vati.)

研究者

发起方
Dr. Snehal Laxman Gaikwad
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Snehal Laxman Gaikwad

Yashwant Ayurvedic College PGT and RC Kodoli

研究点 (1)

Loading locations...

相似试验

To study the effect of Yamanipanchak tablet 250 mg... | 临床试验